Trader consensus favors "No" at 61.5% implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the absence of any current Level 3 alerts and stable epidemiological surveillance data showing no imminent escalations. The CDC lists zero Level 3 ("Reconsider Nonessential Travel") notices, with recent Level 2 updates—including meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte (March 10)—reflecting contained outbreaks without broader transmission risks. H5N1 avian influenza monitoring confirms sporadic human cases among exposed workers, lacking person-to-person spread, per the agency's March 6 situation summary. No significant developments in the past 30 days signal upgrades, though ongoing global outbreak tracking could shift odds with new case surges or model forecasts.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Los CDC emiten una advertencia de Nivel 3 antes del 31 de diciembre?
¿Los CDC emiten una advertencia de Nivel 3 antes del 31 de diciembre?
Sí
$116,287 Vol.
$116,287 Vol.
31 dic 2026
Sí
$116,287 Vol.
$116,287 Vol.
31 dic 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus favors "No" at 61.5% implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the absence of any current Level 3 alerts and stable epidemiological surveillance data showing no imminent escalations. The CDC lists zero Level 3 ("Reconsider Nonessential Travel") notices, with recent Level 2 updates—including meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte (March 10)—reflecting contained outbreaks without broader transmission risks. H5N1 avian influenza monitoring confirms sporadic human cases among exposed workers, lacking person-to-person spread, per the agency's March 6 situation summary. No significant developments in the past 30 days signal upgrades, though ongoing global outbreak tracking could shift odds with new case surges or model forecasts.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercado abierto: Jan 19, 2026, 3:15 PM ET
Volumen
$116,287Fecha de finalización
31 dic 2026Mercado abierto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus favors "No" at 61.5% implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the absence of any current Level 3 alerts and stable epidemiological surveillance data showing no imminent escalations. The CDC lists zero Level 3 ("Reconsider Nonessential Travel") notices, with recent Level 2 updates—including meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte (March 10)—reflecting contained outbreaks without broader transmission risks. H5N1 avian influenza monitoring confirms sporadic human cases among exposed workers, lacking person-to-person spread, per the agency's March 6 situation summary. No significant developments in the past 30 days signal upgrades, though ongoing global outbreak tracking could shift odds with new case surges or model forecasts.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volumen
$116,287Fecha de finalización
31 dic 2026Mercado abierto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus favors "No" at 61.5% implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the absence of any current Level 3 alerts and stable epidemiological surveillance data showing no imminent escalations. The CDC lists zero Level 3 ("Reconsider Nonessential Travel") notices, with recent Level 2 updates—including meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte (March 10)—reflecting contained outbreaks without broader transmission risks. H5N1 avian influenza monitoring confirms sporadic human cases among exposed workers, lacking person-to-person spread, per the agency's March 6 situation summary. No significant developments in the past 30 days signal upgrades, though ongoing global outbreak tracking could shift odds with new case surges or model forecasts.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes